Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Clinical trial NCT04068896 · COMPLETED
Trial details
- NCT number
- NCT04068896
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2023-09-21
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.